Table of Content

1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17

2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on the Market 21
2.2 Major Growth Drivers 23
2.3 Market Restraints and Challenges 27
2.4 Emerging Opportunities and Market Trends 30
2.5 Porter’s Fiver Forces Analysis 34

3 Segmentation of North America Market by Drug Class 38
3.1 Market Overview by Drug Class 38
3.2 Cephalosporin 40
3.3 Penicillin 42
3.4 Macrolides 43
3.5 Tetracycline 44
3.6 Quinolones 45
3.7 Sulfonamides 46
3.8 Aminoglycosides 47
3.9 Other Drug Classes 48

4 Segmentation of North America Market by Action Mechanism 49
4.1 Market Overview by Action Mechanism 49
4.2 Cell Wall Synthesis Inhibitors 51
4.3 Mycolic Acid Inhibitors 52
4.4 RNA Synthesis Inhibitors 53
4.5 DNA Synthesis Inhibitors 54
4.6 Protein Synthesis Inhibitors 55
4.7 Other Mechanisms 56

5 Segmentation of North America Market by Drug Origin 57
5.1 Market Overview by Drug Origin 57
5.2 Natural Antibiotics 59
5.3 Semi-synthetic Antibiotics 60
5.4 Synthetic Antibiotics 61

6 Segmentation of North America Market by Activity Spectrum 62
6.1 Market Overview by Activity Spectrum 62
6.2 Broad-spectrum Antibiotics 64
6.3 Narrow-spectrum Antibiotics 65

7 Segmentation of North America Market by Application 66
7.1 Market Overview by Application 66
7.2 Urinary Tract Infections (UTIS) 68
7.3 Dental Infections 69
7.3.1 Monotherapies for Dental Infections 70
7.3.2 Combined Therapies for Dental Infections 71
7.4 Respiratory Tract Infections (RTIS) 72
7.4.1 Upper Respiratory Tract Infections (URTI) 73
7.4.2 Lower Respiratory Tract Infections (LRTIs) 74
7.5 Other Applications 75

8 Segmentation of North America Market by Drug Type 76
8.1 Market Overview by Drug Type 76
8.2 Brand Antibiotics 78
8.3 Generic Antibiotics 79

9 North America Market 2019-2030 by Country 80
9.1 Overview of North America Market 80
9.2 U.S. 83
9.3 Canada 87
9.4 Mexico 89

10 Competitive Landscape 91
10.1 Overview of Key Vendors 91
10.2 New Product Launch, Partnership, Investment, and M&A 94
10.3 Company Profiles 95
Abbott Laboratories 95
Astellas Pharma 97
AstraZeneca Plc 98
Bayer AG 99
Bristol Myers Squibb Company 100
Cipla Inc. 101
Dr. Reddy’s Laboratories Ltd. 102
Eli Lilly and Company 103
F. Hoffmann-La Roche Ltd. 104
Gilead Sciences, Inc. 105
GlaxoSmithKline plc. 106
Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals) 107
Mayne Pharma Group Ltd. 108
MELINTA THERAPEUTICS, INC. 109
Merck KGaA 110
Novartis AG 111
Pfizer Inc. 112
Sanofi 113
Sun Pharmaceutical Industries Ltd. 114

11 Investing in North America Market: Risk Assessment and Management 115
11.1 Risk Evaluation of North America Market 115
11.2 Critical Success Factors (CSFs) 118
Related Reports and Products 121



List of Figures


Figure 1. Research Method Flow Chart 11
Figure 2. Breakdown of Primary Research 13
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 4. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 17
Figure 5. North America Oral Antibiotics Market, 2019-2030, $ mn 20
Figure 6. Impact of COVID-19 on Business 21
Figure 7. Primary Drivers and Impact Factors of North America Oral Antibiotics Market 23
Figure 8. GDP per capita in the World, 1960-2018, $ thousand 26
Figure 9. Forecast of Middle-class Population by Region, 2015-2030, million 26
Figure 10. Primary Restraints and Impact Factors of North America Oral Antibiotics Market 27
Figure 11. Investment Opportunity Analysis 31
Figure 12. Porter’s Fiver Forces Analysis of North America Oral Antibiotics Market 34
Figure 13. Breakdown of North America Oral Antibiotics Market by Drug Class, 2019-2030, % of Revenue 39
Figure 14. North America Addressable Market Cap in 2020-2030 by Drug Class, Value ($ mn) and Share (%) 39
Figure 15. North America Oral Antibiotics Market: Cephalosporin, 2019-2030, $ mn 40
Figure 16. North America Oral Antibiotics Market: Penicillin, 2019-2030, $ mn 42
Figure 17. North America Oral Antibiotics Market: Macrolides, 2019-2030, $ mn 43
Figure 18. North America Oral Antibiotics Market: Tetracycline, 2019-2030, $ mn 44
Figure 19. North America Oral Antibiotics Market: Quinolones, 2019-2030, $ mn 45
Figure 20. North America Oral Antibiotics Market: Sulfonamides, 2019-2030, $ mn 46
Figure 21. North America Oral Antibiotics Market: Aminoglycosides, 2019-2030, $ mn 47
Figure 22. North America Oral Antibiotics Market: Other Drug Classes, 2019-2030, $ mn 48
Figure 23. Breakdown of North America Oral Antibiotics Market by Action Mechanism, 2019-2030, % of Sales Revenue 50
Figure 24. North America Addressable Market Cap in 2020-2030 by Action Mechanism, Value ($ mn) and Share (%) 50
Figure 25. North America Oral Antibiotics Market: Cell Wall Synthesis Inhibitors, 2019-2030, $ mn 51
Figure 26. North America Oral Antibiotics Market: Mycolic Acid Inhibitors, 2019-2030, $ mn 52
Figure 27. North America Oral Antibiotics Market: RNA Synthesis Inhibitors, 2019-2030, $ mn 53
Figure 28. North America Oral Antibiotics Market: DNA Synthesis Inhibitors, 2019-2030, $ mn 54
Figure 29. North America Oral Antibiotics Market: Protein Synthesis Inhibitors, 2019-2030, $ mn 55
Figure 30. North America Oral Antibiotics Market: Other Mechanisms, 2019-2030, $ mn 56
Figure 31. Breakdown of North America Oral Antibiotics Market by Drug Origin, 2019-2030, % of Sales Revenue 58
Figure 32. North America Addressable Market Cap in 2020-2030 by Drug Origin, Value ($ mn) and Share (%) 58
Figure 33. North America Oral Antibiotics Market: Natural Antibiotics, 2019-2030, $ mn 59
Figure 34. North America Oral Antibiotics Market: Semi-synthetic Antibiotics, 2019-2030, $ mn 60
Figure 35. North America Oral Antibiotics Market: Synthetic Antibiotics, 2019-2030, $ mn 61
Figure 36. Breakdown of North America Oral Antibiotics Market by Activity Spectrum, 2019-2030, % of Revenue 63
Figure 37. North America Addressable Market Cap in 2020-2030 by Activity Spectrum, Value ($ mn) and Share (%) 63
Figure 38. North America Oral Antibiotics Market: Broad-spectrum Antibiotics, 2019-2030, $ mn 64
Figure 39. North America Oral Antibiotics Market: Narrow-spectrum Antibiotics, 2019-2030, $ mn 65
Figure 40. Breakdown of North America Oral Antibiotics Market by Application, 2019-2030, % of Revenue 67
Figure 41. North America Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%) 67
Figure 42. North America Oral Antibiotics Market: Urinary Tract Infections (UTIS), 2019-2030, $ mn 68
Figure 43. North America Oral Antibiotics Market: Dental Infections, 2019-2030, $ mn 69
Figure 44. North America Oral Antibiotics Market: Monotherapies for Dental Infections, 2019-2030, $ mn 70
Figure 45. North America Oral Antibiotics Market: Combined Therapies for Dental Infections, 2019-2030, $ mn 71
Figure 46. North America Oral Antibiotics Market: Respiratory Tract Infections (RTIS), 2019-2030, $ mn 72
Figure 47. North America Oral Antibiotics Market: Upper Respiratory Tract Infections (URTI), 2019-2030, $ mn 73
Figure 48. North America Oral Antibiotics Market: Lower Respiratory Tract Infections (LRTIs), 2019-2030, $ mn 74
Figure 49. North America Oral Antibiotics Market: Other Applications, 2019-2030, $ mn 75
Figure 50. Breakdown of North America Oral Antibiotics Market by Drug Type, 2019-2030, % of Revenue 76
Figure 51. North America Addressable Market Cap in 2020-2030 by Drug Type, Value ($ bn) and Share (%) 77
Figure 52. North America Oral Antibiotics Market: Brand Antibiotics, 2019-2030, $ bn 78
Figure 53. North America Oral Antibiotics Market: Generic Antibiotics, 2019-2030, $ bn 79
Figure 54. Breakdown of North America Oral Antibiotics Market by Country, 2019 and 2030, % of Revenue 81
Figure 55. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 82
Figure 56. U.S. Oral Antibiotics Market, 2019-2030, $ bn 84
Figure 57. Rising Incidence of Infectious Disease in U.S. 84
Figure 58. Canada Oral Antibiotics Market, 2019-2030, $ bn 87
Figure 59. Oral Antibiotics Market in Mexico, 2015-2030, $ bn 89
Figure 60. Growth Stage of North America Oral Antibiotics Industry over the Forecast Period 91



List of Tables


Table 1. Snapshot of North America Oral Antibiotics Market, 2019-2030 18
Table 2. Main Product Trends and Market Opportunities in North America Oral Antibiotics Market 30
Table 3. North America Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 38
Table 4. North America Oral Antibiotics Market: Cephalosporin by Molecule, 2019-2030, $ mn 41
Table 5. North America Oral Antibiotics Market by Action Mechanism, 2019-2030, $ mn 49
Table 6. North America Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 57
Table 7. North America Oral Antibiotics Market by Activity Spectrum, 2019-2030, $ mn 62
Table 8. North America Oral Antibiotics Market by Application, 2019-2030, $ mn 66
Table 9. North America Oral Antibiotics Market: Dental Infections by Type, 2019-2030, $ mn 69
Table 10. North America Oral Antibiotics Market: Respiratory Tract Infections (RTIS) by Type, 2019-2030, $ mn 72
Table 11. North America Oral Antibiotics Market by Drug Type, 2019-2030, $ bn 76
Table 12. North America Oral Antibiotics Market by Country, 2019-2030, $ bn 81
Table 13. U.S. Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 85
Table 14. U.S. Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 85
Table 15. U.S. Oral Antibiotics Market by Application, 2019-2030, $ mn 85
Table 16. Canada Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 88
Table 17. Canada Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 88
Table 18. Canada Oral Antibiotics Market by Application, 2019-2030, $ mn 88
Table 19. Mexico Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 90
Table 20. Mexico Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 90
Table 21. Mexico Oral Antibiotics Market by Application, 2019-2030, $ mn 90
Table 22. Abbott Laboratories: Company Snapshot 95
Table 23. Abbott Laboratories: Business Segmentation 95
Table 24. Abbott Laboratories: Product Portfolio 96
Table 25. Abbott Laboratories: Revenue, 2016-2018, $ mn 96
Table 26. Abbott Laboratories: Recent Developments 96
Table 27. Risk Evaluation for Investing in North America Market, 2019-2030 116
Table 28. Critical Success Factors and Key Takeaways 119